Sodium Deoxyribonucleotide
- Generic Name
- Sodium Deoxyribonucleotide
- Indication
用于急、慢性肝炎，白细胞减少症，血小板减少症及再生障碍性贫血等的辅助治疗。
Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.
- First Posted Date
- 2024-12-24
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Xiangya Hospital of Central South University
- Target Recruit Count
- 400
- Registration Number
- NCT06746701
- Locations
- 🇨🇳
The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳Chenzhou Second People's Hospital, Chenzhou, Hunan, China
🇨🇳First Affiliated Hospital of Nanhua University, Hengyang, Hunan, China
A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B
- Conditions
- Hepatitis B, Chronic
- Interventions
- Drug: TQA3038 injection/placebo
- First Posted Date
- 2024-06-11
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 162
- Registration Number
- NCT06452693
- Locations
- 🇨🇳
Gansu province people hospital, Lanzhou, Gansu, China
🇨🇳The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
🇨🇳Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China
Peginterferon Alpha-2b Therapy in Chronic Hepatitis Patients With Normal ALT Level and Low Viremia
- Conditions
- Chronic Hepatitis B Patients With a Normal ALT Level and Low Viremia
- Interventions
- First Posted Date
- 2022-01-24
- Last Posted Date
- 2022-01-24
- Lead Sponsor
- Fuzhou General Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT05203055
- Locations
- 🇨🇳
Fuzhou General Hospital, Xiamen Univ, Fuzhou, Fujian, China
Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD)
- Conditions
- Hepatitis B, Chronic
- Interventions
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2022-11-02
- Lead Sponsor
- Enyo Pharma
- Target Recruit Count
- 26
- Registration Number
- NCT04465916
- Locations
- 🇵🇱
ENYO PHARMA Investigative site PL01, Białystok, Poland
🇵🇱ENYO PHARMA Investigative site PL02, Lublin, Poland
🇵🇱ENYO PHARMA Investigative site PL03, Warszawa, Poland
To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr /ISGs.
- Conditions
- Hepatitis B
- Interventions
- First Posted Date
- 2018-12-11
- Last Posted Date
- 2023-05-08
- Lead Sponsor
- Sun Yat-sen University
- Target Recruit Count
- 400
- Registration Number
- NCT03771677
- Locations
- 🇨🇳
Chan Xie, Guangzhou, Guangdong, China
A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study
- Conditions
- Human Immunodeficiency Virus Type 1
- Interventions
- First Posted Date
- 2005-08-10
- Last Posted Date
- 2013-06-20
- Lead Sponsor
- Tibotec Pharmaceuticals, Ireland
- Target Recruit Count
- 211
- Registration Number
- NCT00128830
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.